4.7 Article

Effects of a More Selective Arteriovenous Fistula Strategy on Vascular Access Outcomes

Journal

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 34, Issue 9, Pages 1589-1600

Publisher

AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.0000000000000174

Keywords

arteriovenous access; arteriovenous fistula; arteriovenous graft; vascular access

Ask authors/readers for more resources

This study compared two strategies for the choice of initial vascular access in hemodialysis patients. The results showed that a more selective approach to arteriovenous fistula (AVF) placement can reduce the frequency of vascular access procedures and the cost of access management.
Background The optimal choice of initial vascular access-arteriovenous fistula (AVF) or graft (AVG)remains controversial, particularly in patients initiating hemodialysis with a central venous catheter (CVC). Methods In a pragmatic observational study of patients who initiated hemodialysis with a CVC and subsequently received an AVF or AVG, we compared a less selective vascular access strategy of maximizing AVF creation (period 1; 408 patients in 2004 through 2012) with a more selective policy of avoiding AVF creation if failure was likely (period 2; 284 patients in 2013 through 2019). Prespecified end points included frequency of vascular access procedures, access management costs, and duration of catheter dependence. We also compared access outcomes in all patients with an initial AVF or AVG in the two periods. Results An initial AVG placement was significantly more common in period 2 (41%) versus period 1 (28%). Frequency of all access procedures per 100 patient-years was significantly higher in patients with an initial AVF than an AVG in period 1 and lower in period 2. Median annual access management costs were significantly higher among patients with AVF ($10,642) versus patients with AVG ($6810) in period 1 but significantly lower in period 2 ($ 5481 versus $8253, respectively). Years of catheter dependence per 100 patient-years was three-fold higher in patients with AVF versus patients with AVG in period 1 (23.3 versus 8.1, respectively), but only 30% higher in period 2 (20.8 versus 16.0, respectively). When all patients were aggregated, the median annual access management cost was significantly lower in period 2 ($6757) than in period 1 ($9781). Conclusions A more selective approach to AVF placement reduces frequency of vascular access procedures and cost of access management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available